drugset / Trial / NCT02116634

Mesenchymal Stem Cell Injection in Amyotrophic Lateral Sclerosis

NCT02116634

Phase 1/2 Withdrawn Alzahra Hospital, Iran
NaSingle-groupOpen-labelTreatment

Summary

Whether the mesenchymal injection on ALS patients is effective or not?

Timeline

Start
2015-05
Primary completion
2017-05
Completion
2017-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Mesenchymal stem cell Cell therapy 1e+08 cells Other